In a 48-week intervention trial, researchers tested Lutein supplementation for vision protective-function in patients with retinitis pigmentosa (RP). The conclusion of the study was as follows: “Comparing the development of vision measures against the natural loss expected to occur over the course of the 48 weeks, most measures showed reduced decline, and these reductions were significant for normal illumination”.
Ophthalmology (BMC Ophthalmology 2006, 6:23)
For more information and specific research studies by eye condition on nutrition and vision, go to <a href=”http://www.naturaleyecare.com”>Natural Eye Care </a>
Scientists through the US Department of Energy are testing artificial retinas that they hope can restore partial sight to people who’ve lost their vision to the most common causes of blindness.
The Sylmar, Calif., company produced the devices for the U.S. Energy Department’s Artificial Retina Project. The department has been engaged in biological research since the atomic bomb tests of the 1950s raised fears of radiation poisoning.
The current version is being tested on 17 blind people in the U.S. and Europe, and more patients are being enrolled. At a retina conference in October, patients reported improvements in orientation and mobility. They were able to find a door from 20 feet away and to follow a line on the floor for 20 feet.
Meanwhile, researchers in the Energy Department’s National Laboratories are creating a third-generation artificial retina. Much smaller than its predecessors, the device will contain 200 or more electrodes on a thin, flexible film that curves to fit the shape of the retina. Human tests are scheduled to begin in 2011.
For more information and specific research studies by eye condition including nutrition and vision research, go to <a href=”http://www.naturaleyecare.com”>Natural Eye Care </a>
Scientists through the US Department of Energy are testing artificial retinas that they hope can restore partial sight to people who’ve lost their vision to the most common causes of blindness.
The Sylmar, Calif., company produced the devices for the U.S. Energy Department’s Artificial Retina Project. The department has been engaged in biological research since the atomic bomb tests of the 1950s raised fears of radiation poisoning.
The current version is being tested on 17 blind people in the U.S. and Europe, and more patients are being enrolled. At a retina conference in October, patients reported improvements in orientation and mobility. They were able to find a door from 20 feet away and to follow a line on the floor for 20 feet, Mech reported.
Meanwhile, researchers in the Energy Department’s National Laboratories are creating a third-generation artificial retina. Much smaller than its predecessors, the device will contain 200 or more electrodes on a thin, flexible film that curves to fit the shape of the retina. Human tests are scheduled to begin in 2011.
In a 48-week intervention trial, researchers tested Lutein supplementation
for vision protective-function in patients with retinitis pigmentosa (RP). The conclusion of the study was as follows: “Comparing the development of vision measures against the natural loss expected to occur over the course of the 48 weeks, most measures showed reduced decline, and these reductions were significant for normal illumination”.
has been providing comprehensive information on alternative and conventional treatment for vision conditions since 1992. Search this blog and our Website for information on macular degeneration, glaucoma, cataracts, retinal conditions, myopia, and many other vision issues.
